rs11063987
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BA1BP5
This summary comes from the ClinGen Evidence Repository: The NM_000552.5:c.4304A>G variant in VWF is a missense variant predicted to cause substitution of asparagine by serine at amino acid 1435. TThe Grpmax filtering allele frequency in gnomAD v4.1 is 0.1104 (based on 8427/74964 alleles in the African American population[, including 498 homozygotes), which is higher than the ClinGen VWD VCEP threshold of >0.1 for BA1. This variant has been observed in 1 patient with an alternate molecular basis for disease, the presence (with unreported phase) of the p.Arg1341Gln variant, previously classified Pathogenic by the ClinGen VWD Type 2 VCEP (BP5; PMID:30817071). At least 16 healthy adult individuals harboring the p.Asn1435Ser variant were found to be unaffected, with no diagnosis of a bleeding disorder and normal lab values, including bleeding scores lower than 4, VWF:RCo/VWF:Ag ratios >0.6, and no increased response to low-dose ristocetin (PMID:20231421). The mean VWF:RCo/VWF:Ag ratio of 0.71-0.77 within this group was significantly reduced compared to 0.91-0.97 for WT, but above the threshold of <0.6. However, BS2 was not considered due to incomplete penetrance in this gene-disease relationship. In summary this variant is classified as Benign for VWD based on the ACMG/AMP criteria applied, as specified by the ClinGen VWD VCEP: BA1, BP5. LINK:https://erepo.genome.network/evrepo/ui/classification/CA6402552/MONDO:0019565/090
Frequency
Consequence
NM_000552.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VWF | NM_000552.5 | c.4304A>G | p.Asn1435Ser | missense_variant | 28/52 | ENST00000261405.10 | NP_000543.3 | |
VWF | XM_047429501.1 | c.4304A>G | p.Asn1435Ser | missense_variant | 28/52 | XP_047285457.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VWF | ENST00000261405.10 | c.4304A>G | p.Asn1435Ser | missense_variant | 28/52 | 1 | NM_000552.5 | ENSP00000261405.5 | ||
VWF | ENST00000538635.5 | n.421-25180A>G | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0316 AC: 4809AN: 152018Hom.: 271 Cov.: 31
GnomAD3 exomes AF: 0.00818 AC: 2054AN: 251132Hom.: 114 AF XY: 0.00611 AC XY: 829AN XY: 135724
GnomAD4 exome AF: 0.00343 AC: 5017AN: 1461662Hom.: 238 Cov.: 98 AF XY: 0.00294 AC XY: 2141AN XY: 727140
GnomAD4 genome AF: 0.0317 AC: 4817AN: 152136Hom.: 272 Cov.: 31 AF XY: 0.0308 AC XY: 2290AN XY: 74378
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Feb 12, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jun 24, 2022 | - - |
von Willebrand disease type 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
von Willebrand disease type 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
von Willebrand disease type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Hereditary von Willebrand disease Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at